APREA THERAPEUTICS INC
APRE·03836J201·US·Common Stock·Healthcare - Biotechnology-13D/G
APRE (APREA THERAPEUTICS INC) is held by 13 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($90,890), BNP PARIBAS FINANCIAL MARKETS ($30,376), VANGUARD FIDUCIARY TRUST CO ($29,348). Net institutional sentiment: Mixed.
13
Holders
Avg rating(4 Elite)
$247,135
Total Value
43% (17)
Fund Consensus
6 buying - 8 selling
Who's Trading
ActivistVPVestal Point Capital, LP9.9%May 15, 2026
ActivistOHOrin Hirschman9.9%Apr 27, 2026
ActivistSMSquadron Master Fund LP9.9%Apr 7, 2026
ActivistSPSoleus Private Equity Fund III, L.P.10.0%Apr 1, 2026
ActivistNANantahala Capital Management, LLC4.5%Feb 13, 2026
InsiderDMDuey MarcBuy $25KDec 10, 2025
InsiderHPHamill John P.Buy $6KDec 10, 2025
ActivistLLLYTTON LAURENCE W9.9%Nov 17, 2025
InsiderGOGilad OrenBuy $4KApr 3, 2025
InsiderGOGilad OrenBuy $6KApr 3, 2025
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer